Results 21 to 30 of about 20,063 (216)

Comparative Activity of Carbapenem Antibiotics Against Gram-Negative Carbapenemase Producers of Different Groups

open access: yesАнтибиотики и Химиотерапия, 2022
The rapid spread of gram-negative bacteria resistance to carbapenems due to the production of carbapenemases requires new treatment options. The activity of carbapenem antibiotic biapenem, recently registered in Russia, against producers of various ...
V. A. Ageevets   +9 more
doaj   +1 more source

Class A carbapenemases [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2007
Carbapenems, such as imipenem and meropenem, are most often used to treat infections caused by enterobacteria that produce extended-spectrum beta-lactamases, and the emergence of enzymes capable of inactivating carbapenems would therefore limit the options for treatment.
Walther-Rasmussen, J., Høiby, N.
openaire   +2 more sources

Carbapenemase-Producing Enterobacteriaceae [PDF]

open access: yesSeminars in Respiratory and Critical Care Medicine, 2015
Carbapenemase-producing Enterobacteriaceae (CPE) were almost nonexistent up to the 1990s, but are today encountered routinely in hospitals and other healthcare facilities in many countries including the United States. KPC-producing Klebsiella pneumoniae was the first to emerge and spread globally and is endemic in the United States, Israel, Greece, and
Doi, Yohei, Paterson, David L.
openaire   +5 more sources

In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018

open access: yesJournal of Global Antimicrobial Resistance, 2021
: Objectives: This study reports the antimicrobial activity of ceftazidime/avibactam (CZA) and comparators against carbapenemase-producing Enterobacterales (N = 1992) and carbapenemase-producing Pseudomonas aeruginosa (N = 784) collected in Africa/Middle
Pattarachai Kiratisin   +2 more
doaj   +1 more source

Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization

open access: yesАнтибиотики и Химиотерапия, 2020
The resistance of Enterobacterales to carbapenems can be realized by different mechanisms, but the most common one is enzymatic, associated with the production of carbapenemases.
S. V. Yakovlev   +2 more
doaj   +1 more source

All information of BioSamples from isolates harboring carbapenemases.

open access: yes, 2023
All information of BioSamples from isolates harboring carbapenemases.
Yeganeh Malek Mohammadi (17403594)   +4 more
core   +1 more source

OXA-type carbapenemases [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2006
In recent years, the number of class D beta-lactamases with carbapenem-hydrolysing properties has increased substantially. Based on amino acid sequence identities, these class D or OXA-type carbapenemases are divided into eight distantly related groups, and they are only remotely related to other class D beta-lactamases.
Walther-Rasmussen, J., Høiby, Niels
openaire   +2 more sources

NitroSpeed-carba NP test for rapid detection and differentiation between different classes of carbapenemases in Enterobacterales [PDF]

open access: yes, 2020
A biochemical test (NitroSpeed-Carba NP test) was developed to identify carbapenemase production in Enterobacterales and to discriminate between the different types of clinically significant carbapenemases (Ambler classes A, B, and D).
Demord, Anthony   +3 more
core   +2 more sources

Number of detected peptides from (potential) β lactamases or carbapenemases.

open access: yes, 2023
Number of detected peptides from (potential) β lactamases or carbapenemases.
Holger C. Scholz (9118844)   +5 more
core   +1 more source

Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases [PDF]

open access: yes, 2021
Background: ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, the Middle East, Eastern Europe and Latin America, though rarer elsewhere. Because P. aeruginosa readily mutate to become carbapenem resistant via loss of
Vickers, Anna   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy